{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "exchange": "NYQ", "shortName": "Merck & Company, Inc.", "longName": "Merck & Co., Inc.", "messageBoardId": "finmb_288502", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.34879085, "regularMarketPrice": 117.14, "marketState": "PRE", "firstTradeDateMilliseconds": -252322200000, "priceHint": 2, "epsTrailingTwelveMonths": 5.12, "epsForward": 8.49, "epsCurrentYear": 6.98, "priceEpsCurrentYear": 16.782234, "sharesOutstanding": 2537440000, "bookValue": 18.457, "fiftyDayAverage": 111.5344, "fiftyDayAverageChange": 5.6055984, "fiftyDayAverageChangePercent": 0.05025892, "twoHundredDayAverage": 102.6117, "twoHundredDayAverageChange": 14.528297, "twoHundredDayAverageChangePercent": 0.14158519, "marketCap": 299163844608, "forwardPE": 13.797409, "priceToBook": 6.3466434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "preMarketChange": -0.040000916, "preMarketChangePercent": -0.034147955, "preMarketTime": 1684155414, "preMarketPrice": 117.1, "regularMarketChange": -0.41000366, "regularMarketTime": 1683921787, "regularMarketDayHigh": 118.55, "regularMarketDayRange": "116.695 - 118.55", "regularMarketDayLow": 116.695, "regularMarketVolume": 5233088, "regularMarketPreviousClose": 117.55, "bid": 116.52, "ask": 117.14, "bidSize": 8, "askSize": 8, "fullExchangeName": "NYSE", "financialCurrency": "USD", "regularMarketOpen": 118.0, "averageDailyVolume3Month": 7554798, "averageDailyVolume10Day": 5770290, "fiftyTwoWeekLowChange": 34.089996, "fiftyTwoWeekLowChangePercent": 0.41047555, "fiftyTwoWeekRange": "83.05 - 119.65", "fiftyTwoWeekHighChange": -2.5100021, "fiftyTwoWeekHighChangePercent": -0.02097787, "fiftyTwoWeekLow": 83.05, "fiftyTwoWeekHigh": 119.65, "dividendDate": 1681084800, "earningsTimestamp": 1690891200, "earningsTimestampStart": 1690891200, "earningsTimestampEnd": 1690891200, "trailingAnnualDividendRate": 2.8, "trailingPE": 22.878906, "trailingAnnualDividendYield": 0.02381965, "displayName": "Merck &", "symbol": "MRK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "126 East Lincoln Avenue", "city": "Rahway", "state": "NJ", "zip": "07065", "country": "United States", "phone": "908 740 4000", "website": "https://www.merck.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.", "fullTimeEmployees": 67000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert M. Davis J.D.", "age": 55, "title": "Chairman, Pres & CEO", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 6076253, "fmt": "6.08M", "longFmt": "6,076,253"}, "exercisedValue": {"raw": 6766101, "fmt": "6.77M", "longFmt": "6,766,101"}, "unexercisedValue": {"raw": 18304676, "fmt": "18.3M", "longFmt": "18,304,676"}}, {"maxAge": 1, "name": "Ms. Caroline  Litchfield", "age": 53, "title": "Exec. VP & CFO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 2801844, "fmt": "2.8M", "longFmt": "2,801,844"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 8916697, "fmt": "8.92M", "longFmt": "8,916,697"}}, {"maxAge": 1, "name": "Ms. Jennifer L. Zachary", "age": 44, "title": "Exec. VP & Gen. Counsel", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 2732334, "fmt": "2.73M", "longFmt": "2,732,334"}, "exercisedValue": {"raw": 3461623, "fmt": "3.46M", "longFmt": "3,461,623"}, "unexercisedValue": {"raw": 4142191, "fmt": "4.14M", "longFmt": "4,142,191"}}, {"maxAge": 1, "name": "Dr. Dean Y. Li M.D., Ph.D.", "age": 60, "title": "Exec. VP & Pres of Merck Research Laboratories", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 3442288, "fmt": "3.44M", "longFmt": "3,442,288"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3893921, "fmt": "3.89M", "longFmt": "3,893,921"}}, {"maxAge": 1, "name": "Mr. Chirfi  Guindo", "age": 56, "title": "Sr. VP & Chief Marketing Officer for Merck Human Health", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 1541708, "fmt": "1.54M", "longFmt": "1,541,708"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David Michael Williams", "age": 53, "title": "Exec. VP and Chief Information & Digital Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Dannenbaum", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Lisa  LeCointe-Cephas", "age": 40, "title": "Sr. VP and Chief Ethics & Compliance Officer", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cristal N. Downing", "age": 52, "title": "Exec. VP and Chief Communications & Public Affairs Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Steven C. Mizell", "age": 62, "title": "Exec. VP & Chief HR Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 4, "compensationRisk": 5, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}